PROFILE ASSESSMENT FOR HOSPITAL READMISSIONAMONG MALE PATIENTS OF ACUTE EXACERBATIONCHRONIC OBSTRUCTIVE PULMONARY DISEASEAT SELECTED HOSPITAL IN MALAYSIA

Authors

  • Nur Syafa Addina Binti Dzakwan Department of Bachelor of Pharmacy Candidate, Management and Science University, Malaysia.
  • Enti Hariadha Department of Lecturer of Clinical Pharmacy Unit, Management and Science University, Malaysia

DOI:

https://doi.org/10.22159/ajpcr.2017.v10s2.19476

Keywords:

Readmission, Chronic obstructive pulmonary disease, Acute exacerbation of chronic obstructive pulmonary disease, Medication cost

Abstract

Background:Chronic Obstructive Pulmonary Disease (AECOPD) is a commonlung disease characterized by airflow limitation that is not fully reversible and is both chronic and progressive. Acute Exacerbation of COPD (AECOPD) is a suddenworsening of COPD symptoms that typically lasts for several days. AECOPDreadmission has been one of global concern and was the fifth leading cause of disease burden in Malaysia, both clinically and economically.

Objective: This study is aimed to screen the factors are contributed to readmission among AECOPD male patients in selected hospital of Malaysia and associated medication cost.

Methods: A cross-sectional study design was used in this study, whereby data collections were based upon AECOPD Patient's Medical Record that was readmitted to the Male Medical ward from 1st January to 31st December 2015 and documented into the patient's data collection form. The collected data were analysed by using software name Statistical Package for Social Sciences version 17.0 (SPSS 17.0).

Results: Total sample population collected was 100 patients during the study period. Majority of patients aged from 50-79 years old (83%) and 74% of them were Malays. The 94% of them were associated with cigarette smoking and 93% were having concomitant disease of cardiovascular disorder& endocrine disorder. Out of 100 study population, 32% patients were readmitted back in more than one year since previous hospitalization, while 40% was readmitted back within less than thirty days. The longest day of hospitalization spent 12 days but majority (56%) spent less than five days of hospitalization. Combinations between Augmentin and Azithromycin were the common (45%) antibiotics prescribed among the study population. Significantly statistical difference (P < 0.05) are shown between cigarette smoking habits on different groups of age and between time readmission after discharge with medication adherence, while no significantly statistical difference (P > 0.05) between length of stay with medication cost during admission.

Conclusion: The readmission factors were contributed among AECOPD in selected hospital were revealed highest among Malay aged between 50-79 years old, associated with cigarettes smoking and not adhere to medications. Medication cost during admission was not significantly increasing proportionally with length of stay.

  

 

Downloads

Download data is not yet available.

References

Aït-Khaled N, Enarson D, Bousquet J. Chronic respiratory diseases in developing countries: The burden and strategies for prevention and management. Bull World Health Organ 2001;79(10):971-9.

Dipiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM. Pharmacotherapy: A Pathophysiologic Approach. New York: McGraw-Hill Companies; 2011. p. 495-6.

Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest J 2000;117 Suppl 5:398S-401.

Regional COPD Working Group. COPD prevalence in 12 Asia-Pacific countries and regions: Projections based on the COPD prevalence estimation model. Respirology 2003;8(2):192-8.

Lundback B, Lindberg A, Lindstrom M, Rönmark E, Jonsson AC, Jönsson E, et al. Not 15 but 50% of smokers develop COPD? Report from the obstructive lung Disease in Northern Sweden studies. Respir Med 2003;97 Suppl 2:115-22.

Ministry of Health Malaysia. Clinical practice guidelines. Management of Chronic Obstructive Pulmonary Disease. 2nd ed. Malaysia: Academy of Medicine of Malaysia, Malaysian Thoracic Society; 2009. p. 1-67.

Cosimo MB, Maria V. Acid-base disorders in patients with chronic obstructive pulmonary disease: A pathophysiological review. J Biomed Biotechnol 2012;2012:1-8.

Adams SG, Jairo M, Michael L, Antonio A. Antibiotics are associated with lower relapse rates in outpatients with acute exacerbations of COPD. Chest J 2000;117 Suppl 5:1345-52.

Dalal AA, Shah M, D’Souza AO, Rane P. Costs of COPD exacerbations in the emergency department and inpatient setting. Respir Med 2011;105 Suppl 3:454-60.

Published

01-05-2017

How to Cite

Dzakwan, N. S. A. B., and E. Hariadha. “PROFILE ASSESSMENT FOR HOSPITAL READMISSIONAMONG MALE PATIENTS OF ACUTE EXACERBATIONCHRONIC OBSTRUCTIVE PULMONARY DISEASEAT SELECTED HOSPITAL IN MALAYSIA”. Asian Journal of Pharmaceutical and Clinical Research, vol. 10, no. 14, May 2017, pp. 21-24, doi:10.22159/ajpcr.2017.v10s2.19476.

Issue

Section

Original Article(s)